Payam Nahid
机构: University of California, San Francisco
每年引用次数
引用次数
引用: 12,814
H-指数: 46
I10-指数 : 97
出版物: 198
Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
Paul D. Piehowski , Marina A. Gritsenko , David M. Lewinsohn , George B. Sigal
PLOS ONE 16 ( 5)
2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Susan E Dorman , Payam Nahid , Ekaterina V Kurbatova , Patrick PJ Phillips
The New England Journal of Medicine 384 ( 18) 1705 -1718
202
2021
A systematic review of endpoint definitions in late phase tuberculosis therapeutic trials
Patrick P.J. Phillips , Rada Savic , Payam Nahid , Johnson Lyimo
2021
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens.
Carol Wilusz , Dissou Affolabi , Gary Schoolnik , Helen McIlleron
Nature Communications 12 ( 1) 2899 -2899
2021
Towards tuberculosis elimination: an action framework for low-incidence countries
Knut Lönnroth , Giovanni Battista Migliori , Ibrahim Abubakar , Lia D'Ambrosio
European Respiratory Journal 45 ( 4) 928 -952
782
2015
Detection of Mycobacterium tuberculosis Peptides in the Exosomes of Patients with Active and Latent M. tuberculosis Infection Using MRM-MS
Nicole A. Kruh-Garcia , Lisa M. Wolfe , Lelia H. Chaisson , William O. Worodria
PLoS ONE 9 ( 7) e103811
85
2014
Challenges in the clinical assessment of novel tuberculosis drugs
Kelly E. Dooley , Patrick P.J. Phillips , Payam Nahid , Michael Hoelscher
Advanced Drug Delivery Reviews 102 116 -122
10
2016
Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis.
Christopher A. Berger , Narges Alipanah , Fayez Kheir , Joseph K. Ruminjo
Annals of the American Thoracic Society 17 ( 8) 911 -917
1
2020
Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.
David J Horne , Sarah E Royce , Lisa Gooze , Masahiro Narita
Lancet Infectious Diseases 10 ( 6) 387 -394
159
2010
Multidrug-resistant tuberculosis - Authors' reply.
Dick Menzies , Andrea Benedetti , Giovanni B Migliori , Payam Nahid
The Lancet 394 ( 10195) 299 -300
2
2019
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad , Shama D Ahuja , Onno W Akkerman , Jan-Willem C Alffenaar
The Lancet 392 ( 10150) 821 -834
410
2018
Advances in the development of new tuberculosis drugs and treatment regimens
Alimuddin Zumla , Payam Nahid , Stewart T. Cole
Nature Reviews Drug Discovery 12 ( 5) 388 -404
1,037
2013
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
Narges Alipanah , Leah Jarlsberg , Cecily Miller , Nguyen Nhat Linh
PLOS Medicine 15 ( 7)
67
2018
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
Martin J. Boeree , Michael Hoelscher , Patrick P. J. Phillips , Kelly E. Dooley
BMC Medicine 14 ( 1) 51 -51
14
2016
Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.
Christina Yoon , J. Lucian Davis , Laurence Huang , Conrad Muzoora
Journal of Acquired Immune Deficiency Syndromes 65 ( 5) 551 -556
21
2014
Childhood Tuberculosis in Northern Viet Nam: A Review of 103 Cases
Robert J. Blount , Bao Tran , Leah G. Jarlsberg , Ha Phan
PLoS ONE 9 ( 5) e97267
20
2014
Clinical Research and Development of Tuberculosis Diagnostics: Moving From Silos to Synergy
Payam Nahid , Peter S Kim , Carlton A Evans , David Alland
The Journal of Infectious Diseases 205
27
2012
A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
George B. Sigal , Abraham Pinter , Todd L. Lowary , Masanori Kawasaki
Journal of Clinical Microbiology 56 ( 12)
91
2018
Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening.
Narges Alipanah , Priya B. Shete , Hanh Nguyen , Nhung Viet Nguyen
Diagnostics (Basel, Switzerland) 9 ( 2) 56 -56
2019
Advances in clinical trial design for development of new TB treatments: A call for innovation.
Christian Lienhardt , Payam Nahid
PLOS Medicine 16 ( 3)
11
2019